- Chinese startups across medtech, clean energy, robotics and AI infrastructure secured fresh funding to accelerate technology development and commercialization
- The latest rounds will back global medtech expansion, AI power infrastructure, robot vision and sensing, agentic EDA and embodied robotics
Kossel Medical raises shy of $60 million in Series C funding round
Suzhou-based Kossel Medical (科塞尔医疗科技) has completed a 400 million yuan ($59.5 million) Series C round, jointly led by Shenzhen Capital Group and Kinghall Ventures, with Frontier Venture Capital and Chuangjing Capital participating.
Existing investors including Suzhou Capital Group, Suzhou New District Financial Holding, Suzhou New District High-Tech and In Capital also increased their positions. The company confirmed the financing on September 1.
Founded in 2013, Kossel is a national-level “Little Giant” company specializing in vascular interventional medical devices. It has built a business portfolio spanning peripheral intervention, coronary intervention and cardiac electrophysiology, with core products already registered in multiple overseas markets.
The company has pursued a platform-based strategy through acquisitions and partnerships this year, seeking to combine its product portfolio with distribution capabilities and help more Chinese medical-device innovations enter international markets.
The latest funding will be used to expand production capacity, advance R&D and global registration of core products, and deepen its overseas localization strategy.
Cleantech operator PCG Power completes Series C1 financing
Hangzhou-based clean-energy asset operator PCG Power (碧澄能源) has completed a Series C1 financing round worth hundreds of millions of yuan, led by Zhonghai Fund, with Chengdu Communications Investment Group and Yankuang Capital participating.
Founded four years ago, PCG Power invests in and operates distributed clean-energy projects for commercial and industrial customers. Its cumulative connected capacity has reached nearly 2 gigawatts.
The company has attracted backing from international long-term investors including Temasek, Saudi Aramco’s venture arm and Eurazeo, alongside Chinese industrial and financial investors.
The latest round brings in additional Middle Eastern sovereign fund and is expected to support expansion into the Gulf region and other overseas markets.
The company is also developing an “Energy for AI” business aimed at meeting the power requirements of AI computing centers, alongside its digital electricity-trading platform and broader energy-asset portfolio.
PCG Power has also been developing an asset-securitization model for clean-energy infrastructure. In August, a clean-energy asset-backed special plan linked to the company completed its first 2026 expansion, raising more than 800 million yuan in total.
Camera module maker United Imaging raises hundreds of millions of yuan
Hangzhou-based United Imaging (联合影像) has completed a new financing round worth hundreds of millions of yuan. Investors include Dunhong Capital Management, the Hangzhou Embodied Intelligence Industry Fund, Fuyang Industrial Development and AI² Robotics.
Founded in 2014, United Imaging specializes in CMOS camera modules, visual solutions and imaging systems.
Its customers include humanoid-robot and AI-hardware companies such as Unitree, AI² Robotics, X Square Robot and Rokid. The company has reached annual revenue in the range of 2 billion yuan.
United Imaging is positioning itself as a “visual infrastructure” provider for the physical AI era, integrating optical design, camera modules, depth cameras, edge AI, data collection, AI-base engineering tools and large-scale manufacturing.
The company is also developing a 10-billion-yuan-class intelligent-vision industrial project in Hangzhou.
The new funding will support depth cameras, edge AI vision, data collection and construction of the Hangzhou intelligent-vision industrial base. Recent reports also confirmed the company’s latest financing and its investor lineup.
Encoder developer Gongwang Sensor nets nearly $15 million
Wuxi-based Gongwang Sensor (弓望传感), a developer of next-generation inductive encoders, has completed an A round of nearly 100 million yuan ($15 million).
The round was led by Nio Capital, with participation from Xiamen Tungsten Industrial Fund, Sungrow Fund, Fortune+ Ventures, Gloss Capital and Shenzhen Dawu Capital.
Founded in 2021, the company has a core team with nearly two decades of experience developing and mass-producing inductive sensor products. It has built an automated production line with annual capacity of 15 million encoders.
Its inductive encoders are used in industrial automation, robotic joints and high-precision manufacturing. For robotics, the company has developed an ultra-narrow-frame dual encoder with co-planar architecture and entered the supply chains of several leading domestic robot manufacturers.
In industrial machine tools and semiconductor equipment, its high-precision inductive rotary-table encoders offer absolute positioning accuracy of better than ±1 arc second and have entered mass production.
The latest funding will accelerate large-scale deployment of its inductive encoder technology in robotics and high-precision manufacturing.
Haofeng Medical bags nearly $15 million in strategic funding
Shanghai-based interventional medical-device CDMO provider Haofeng Medical (昊丰医疗) has completed a strategic financing round worth nearly 100 million yuan ($15 million) from Huayin Financial Investment.
Founded in 2020, Haofeng operates four industrial platforms covering consumables, equipment, energy-based devices and materials.
It provides interventional-device companies with one-stop CDMO services spanning product development through mass production.
The new capital will be used to expand its manufacturing base in Fengxian, Shanghai, accelerate commercialization across its four platforms and support domestic and international regulatory filings.
The company aims to provide global interventional-medical-device brands with full-lifecycle CDMO services, from R&D and engineering to manufacturing.
ChipFlux secures angel funding to advance AI EDA
Hangzhou-based AI EDA software startup ChipFlux (芯流微澜) has completed an angel round worth tens of millions of yuan, with Inspiration Capital as the sole investor. The financing was reported on September 1.
Founded in 2026, ChipFlux focuses on the intersection of AI and electronic design automation.
Founder Sun Qi (孙奇) is a researcher and doctoral supervisor at Zhejiang University’s School of Integrated Circuits, while technology chief Chen Zhengrui (陈正锐) previously worked on production-grade standard-cell libraries and backend optimization solutions for major international IDM companies.
The company has developed its own domain-specific large model, Wavelet, and an agent engineering framework called Orbit.
Together, the system is designed to understand chip-design objectives, orchestrate industrial EDA tools, analyze results and autonomously determine subsequent optimization steps.
ChipFlux says it has completed full backend physical-design validation on projects involving sub-10-nanometer processes and nearly 10 million gates, making it one of a small number of teams in the sector to have connected AI agents with industrial-grade EDA toolchains and deployed them in advanced-process chip projects.
The new funding will support further product development and market expansion.
AI agent startup Aether Heart closes seed round worth tens of millions of yuan
Shanghai-based AI-agent infrastructure company Aether Heart (以太之心) has completed a seed round worth tens of millions of yuan.
Investors include Shanghai Angel Group, Pudong Venture Capital, Focus Capital and Tianshi Qingfen.
The company focuses on full-stack infrastructure for AI agents and follows a software-hardware co-design approach. Its core products include the Aeloon agent task-orchestration system and AetherStation edge appliance.
The latest funding will support core technology development, productization, hardware adaptation and deployment in benchmark commercial scenarios.
MRI firm Marvel Stone Healthcare completes Series A+ funding round
Wuxi-based compact MRI developer Marvel Stone Healthcare (鸣石峻致) has completed the first closing of an Series A+ round worth tens of millions of yuan, led exclusively by Guosheng Capital. Its cumulative funding has now exceeded 100 million yuan.
Founded in 2019, the company develops specialized compact MRI systems. Its flagship product is a digital small-bore MRI system for fatty-liver disease, while its pipeline also includes mid-field MRI systems designed for brain-computer interfaces and MRI equipment for oil and gas logging.
The latest funding will accelerate regulatory registration of its fatty-liver MRI system and commercialization of its brain-computer-interface MRI products.
Robotics service provider Shunxing Jidian snags seed round
Hangzhou-based embodied-robotics service provider Shunxing Jidian (舜行奇点) has completed a seed round worth tens of millions of yuan.
Investors include Galbot, Five Ages, Yinxinggu Capital, Hangzhou’s state-backed Runmiao Fund, Zhaofeng and InvesTarget.
Founded in late 2025, Shunxing Jidian positions itself as a one-stop service provider for embodied-robot manufacturers. It provides robot makers with an integrated supply chain covering core components, joint modules and complete-machine mass production and delivery.
The company aims to help robot manufacturers shorten the path from component sourcing and system integration to scaled production.
